A TB patient living with HIV in El Salvador shows his antiretroviral medication.

The Global Fund plays a leading role in global markets for medicines and technologies that prevent, diagnose and treat HIV, tuberculosis and malaria. Every year, roughly half of the Global Fund’s investments – about US$2 billion – is used to procure these key medicines and health products, ensuring they are available to those who need them most and accelerating the end of the epidemics.

The Global Fund / John Rae